Library Clinical Correlations
Molecular Medicine Series

Clinical Correlations Cases

Bridge foundational molecular biology concepts to clinical presentations. Each case integrates presentation, diagnosis, molecular mechanism, and high-yield concept for USMLE mastery.

How to Use These Cases

Each case follows a consistent framework: Presentation → Diagnosis → Molecular Basis → Key Concept. Focus on connecting the molecular mechanism to the clinical phenotype. These cases are designed for active recall practice and integration with your USMLE Step 1/2 CK preparation.

1
DNA Repair Defect
Xeroderma Pigmentosum
Presentation
6-year-old boy with multiple freckles, severe sunburns after minimal sun exposure, and early-onset skin cancer.
Diagnosis
Xeroderma pigmentosum (XP) — autosomal recessive disorder of DNA repair.
Molecular Basis
Defective nucleotide excision repair (NER) pathway; inability to repair UV-induced thymine dimers. Mutations in XPA–XPG genes impair recognition/excision of damaged DNA.
NER pathway • Thymine dimers • XPA–XPG genes
Key Concept
DNA repair mechanisms are essential genomic guardians; defects lead to cancer predisposition. XP illustrates the direct link between environmental exposure (UV), molecular defect (NER), and clinical outcome (skin cancer).
2
Trinucleotide Repeat Disorder
Huntington's Disease
Presentation
35-year-old man with progressive chorea, behavioral changes, and family history of similar symptoms with earlier onset in each successive generation.
Diagnosis
Huntington's disease — autosomal dominant neurodegenerative disorder.
Molecular Basis
CAG trinucleotide repeat expansion in exon 1 of the HTT gene on chromosome 4. ≥36 repeats is pathogenic; longer repeats correlate with earlier onset and more severe disease.
CAG repeat • HTT gene • Gain-of-function toxicity
Key Concept
Anticipation: Earlier onset and increased severity in successive generations due to repeat expansion during meiosis (especially paternal transmission). A hallmark of dynamic mutation disorders.
3
Genomic Imprinting Disorder
Prader-Willi Syndrome
Presentation
Newborn with severe hypotonia, poor feeding, and hypogonadism; develops hyperphagia, obesity, and developmental delay in childhood.
Diagnosis
Prader-Willi syndrome — imprinting disorder of chromosome 15q11-13.
Molecular Basis
Loss of paternally expressed genes at 15q11-13 via: (1) paternal deletion (~70%), (2) maternal uniparental disomy (~25%), or (3) imprinting defect. Critical region includes SNRPN, NDN.
15q11-13 • Paternal deletion • UPD • Imprinting center
Key Concept
Genomic imprinting: Parent-of-origin matters. Same chromosomal region, different phenotype based on which parent contributed the defect (Prader-Willi = paternal loss; Angelman = maternal loss).
4
RNA Splicing Defect
β-Thalassemia
Presentation
Mediterranean patient with microcytic hypochromic anemia, normal iron studies, and elevated HbA₂ on electrophoresis.
Diagnosis
β-Thalassemia — autosomal recessive disorder of β-globin synthesis.
Molecular Basis
Splice site mutation in the β-globin gene (HBB) leading to abnormal mRNA processing, reduced/absent β-globin chains, and α:β chain imbalance → ineffective erythropoiesis.
HBB gene • Splice site • mRNA processing • α:β imbalance
Key Concept
Proper pre-mRNA splicing is essential for functional protein production. Splice site mutations are a common mechanism in genetic disease, particularly in hemoglobinopathies.
5
Missense Point Mutation
Sickle Cell Disease
Presentation
African American child with episodic painful vaso-occlusive crises, dactylitis, chronic hemolytic anemia, and susceptibility to encapsulated organisms.
Diagnosis
Sickle cell disease (HbSS) — autosomal recessive hemoglobinopathy.
Molecular Basis
Single nucleotide substitution (A→T) in codon 6 of the β-globin gene, causing Glu→Val substitution. Hydrophobic valine promotes HbS polymerization under low O₂, distorting RBCs into sickle shape.
β⁶ Glu→Val • HbS polymerization • Hydrophobic interaction
Key Concept
A single amino acid change can profoundly alter protein structure/function and cause systemic disease. Sickle cell is the paradigm for molecular medicine and exemplifies heterozygote advantage (malaria resistance).
6
Antibiotic Mechanism of Action
Aminoglycoside Therapy
Presentation
Patient with severe gram-negative sepsis (e.g., Pseudomonas) treated with gentamicin as part of combination therapy.
Pharmacologic Target
Aminoglycoside antibiotics (gentamicin, tobramycin, amikacin) — bactericidal protein synthesis inhibitors.
Molecular Mechanism
Irreversibly binds the 30S ribosomal subunit, causing misreading of mRNA codons and incorporation of incorrect amino acids → production of nonfunctional/toxic proteins → bacterial cell death. Also blocks initiation complex formation.
30S binding • mRNA misreading • Bactericidal • Concentration-dependent killing
Key Concept
The translation machinery is a selective antibiotic target due to structural differences between prokaryotic (70S) and eukaryotic (80S) ribosomes. Understanding mechanism predicts spectrum, toxicity (ototoxicity, nephrotoxicity), and clinical use.
Back to Library Next Set: Metabolic Pathways

Evidence & Further Reading